Cancer facts and figures 2002 2002 American Cancer Society New York 5
J.G. Smirniotopoulos The new WHO classification of brain tumors Neuroimaging Clin N Am 9 4 1999 595 613
L.M. DeAngelis Brain tumors N Engl J Med 344 2 2001 114 123
P.N. Plowman Stereotactic radiosurgery. VIII. The classification of postradiation reactions Br J Neurosurg 13 3 1999 256 264
P. Giglio, and M.R. Gilbert Cerebral radiation necrosis Neurologist 9 4 2003 180 188
A.J. Kumar, N.E. Leeds, and G.N. Fuller Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment Radiology 217 2 2000 377 384
C. Nieder, N. Andratschke, and R.E. Price Innovative prevention strategies for radiation necrosis of the central nervous system Anticancer Res 22 2A 2002 1017 1023
H.J. Aronen, and J. Perkio Dynamic susceptibility contrast MRI of gliomas Neuroimaging Clin N Am 12 4 2002 501 523
F. Wenz, K. Rempp, and T. Hess Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging AJR Am J Roentgenol 166 1 1996 187 193
H.P. Schlemmer, P. Bachert, and K.K. Herfarth Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy AJNR Am J Neuroradiol 22 7 2001 1316 1324
J.P. Rock, D. Hearshen, and L. Scarpace Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis Neurosurgery 51 4 2002 912 919 [discussion: 919-20]
N.J. Patronas, G. Di Chiro, and R.A. Brooks Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain Radiology 144 4 1982 885 889
G. Di Chiro, E. Oldfield, and D.C. Wright Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies AJR Am J Roentgenol 150 1 1988 189 197
W.K. Doyle, T.F. Budinger, and P.E. Valk Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography J Comput Assist Tomogr 11 4 1987 563 570
P.E. Valk, T.F. Budinger, and V.A. Levin PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome J Neurosurg 69 6 1988 830 838
W.K. Davis, O.B. Boyko, and J.M. Hoffman [18F]2-fluoro-2-deoxyglucose- positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia AJNR Am J Neuroradiol 14 3 1993 515 523
E.E. Kim, S.K. Chung, and T.P. Haynie Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET Radiographics 12 2 1992 269 279
T.J. Janus, E.E. Kim, and R. Tilbury Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors Ann Neurol 33 5 1993 540 548
D. Kahn, K.A. Follett, and D.L. Bushnell Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET AJR Am J Roentgenol 163 6 1994 1459 1465
P.E. Ricci, J.P. Karis, and J.E. Heiserman Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 19 3 1998 407 413
T.P. Thompson, L.D. Lunsford, and D. Kondziolka Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy Stereotact Funct Neurosurg 73 1-4 1999 9 14
D.A. Ross, H.M. Sandler, and J.M. Balter Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors J Neurooncol 56 2 2002 175 181
S.T. Chao, J.H. Suh, and S. Raja The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery Int J Cancer 96 3 2001 191 197
O. Belohlavek, G. Simonova, and I. Kantorova Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? Eur J Nucl Med Mol Imaging 30 1 2003 96 100
G. Di Chiro Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool Invest Radiol 22 5 1987 360 371
J.B. Alavi, A. Alavi, and J. Chawluk Positron emission tomography in patients with glioma. A predictor of prognosis Cancer 62 6 1988 1074 1078
M.V. Padma, S. Said, and M. Jacobs Prediction of pathology and survival by FDG PET in gliomas J Neurooncol 64 3 2003 227 237
G. Di Chiro, and M.J. Fulham Virchow's shackles: can PET-FDG challenge tumor histology? AJNR Am J Neuroradiol 14 3 1993 524 527
N.J. Patronas, G. Di Chiro, and C. Kufta Prediction of survival in glioma patients by means of positron emission tomography J Neurosurg 62 6 1985 816 822
F.G. Barker II, S.M. Chang, and P.E. Valk 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma Cancer 79 1 1997 115 126
J. Mogard, L. Kihlstrom, and K. Ericson Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG J Comput Assist Tomogr 18 2 1994 177 181
K. Ericson, L. Kihlstrom, and J. Mogard Positron emission tomography using 18F-fluorodeoxyglucose in patients with stereotactically irradiated brain metastases Stereotact Funct Neurosurg 66 Suppl 1 1996 214 224
J.E. Powe, J.B. Alavi, and A. Alavi Cerebral metabolic changes in patients with brain tumors demonstrated by positron emission tomography J Neuroimag 2 1992 1 7
M. Pourdehnad, P. Duarte, and A.S. Okpaku Adverse effects of edema on adjacent gray matter function in patients with brain tumor as determined by FDG-PET imaging [abstract] J Nucl Med 40 5 Suppl S 453 1999 112P
M. Kushner, A. Alavi, and M. Reivich Contralateral cerebellar hypometabolism following cerebral insult Ann Neurol 15 5 1984 425 434
W.C. Olivero, S.C. Dulebohn, and J.R. Lister The use of PET in evaluating patients with primary brain tumours: is it useful? J Neurol Neurosurg Psychiatry 58 2 1995 250 252
T.J. Janus, E.E. Kim, and R. Tilbury Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors Ann Neurol 33 5 1993 540 548
C.K. Kim, J.B. Alavi, and A. Alavi New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose J Neurooncol 10 1 1991 85 91
M.A. Meyer, K.A. Frey, and M. Schwaiger Discordance between F-18 fluorodeoxyglucose uptake and contrast enhancement in a brain abscess Clin Nucl Med 18 8 1993 682 684
M. Sasaki, Y. Ichiya, and Y. Kuwabara Ringlike uptake of [18F]FDG in brain abscess: a PET study J Comput Assist Tomogr 14 3 1990 486 487
A.J. Fischman, A.F. Thornton, and M.P. Frosch FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma J Nucl Med 38 7 1997 1027 1029
C.J. Marriott, W. Thorstad, and G. Akabani Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors J Nucl Med 39 8 1998 1376 1380
M. Kameyama, R. Shirane, and J. Itoh The accumulation of 11C-methionine in cerebral glioma patients studied with PET Acta Neurochir (Wien) 104 1-2 1990 8 12
J.M. Derlon, C. Bourdet, and P. Bustany [11C]L-methionine uptake in gliomas Neurosurgery 25 5 1989 720 728
B. Pirotte, S. Goldman, and P. David Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18]fluorodeoxyglucose and [C-11]methionine Acta Neurochir Suppl (Wien) 68 1997 133 138
O. De Witte, I. Goldberg, and D. Wikler Positron emission tomography with injection of methionine as a prognostic factor in glioma J Neurosurg 95 5 2001 746 750
P. Bustany, M. Chatel, and J.M. Derlon Brain tumor protein synthesis and histological grades: a study by positron emission tomography (PET) with C11-L-Methionine J Neurooncol 3 4 1986 397 404
B. Kaschten, A. Stevenaert, and B. Sadzot Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine J Nucl Med 39 5 1998 778 785
K. Kubota, R. Kubota, and S. Yamada Effects of radiotherapy on the cellular uptake of carbon-14 labeled L-methionine in tumor tissue Nucl Med Biol 22 2 1995 193 198
R. Kubota, K. Kubota, and S. Yamada Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG J Nucl Med 36 3 1995 484 492
F.C. Rau, W.A. Weber, and H.J. Wester O-(2-[18F]fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes Eur J Nucl Med 29 8 2002 1039 1046
O.S. Nettelbladt, A.E. Sundin, and S.O. Valind Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum J Nucl Med 39 4 1998 640 647
M.J. Reinhardt, K. Kubota, and S. Yamada Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose. L-methionine and thymidine J Nucl Med 38 2 1997 280 287
U. Roelcke, E.W. Radu, and K. von Ammon Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET J Neurol Sci 132 1 1995 20 27
T. Ogawa, I. Kanno, and F. Shishido Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury Acta Radiol 32 3 1991 197 202
Y. Sonoda, T. Kumabe, and T. Takahashi Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis Neurol Med Chir (Tokyo) 38 6 1998 342 347 [discussion: 347-8]
N. Tsuyuguchi, I. Sunada, and Y. Iwai Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg 98 5 2003 1056 1064
T. Ogawa, I. Kanno, and J. Hatazawa Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain Radiographics 14 1 1994 101 110
J.K. Chung, Y.K. Kim, and S.K. Kim Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET Eur J Nucl Med Mol Imaging 29 2 2002 176 182
M.A. Heesters, K.G. Go, and R.L. Kamman 11C-tyrosine position emission tomography and 1H magnetic resonance spectroscopy of the response of brain gliomas to radiotherapy Neuroradiology 40 2 1998 103 108
K.F. Hubner, J.A. Thie, and G.T. Smith Positron emission tomography (PET) with 1-aminocyclobutane-1-[(11)C]carboxylic acid (1-[(11)C]-ACBC) for detecting recurrent brain tumors Clin Positron Imaging 1 3 1998 165 173
C. Lemaire, S. Gillet, and M. Kameda Enantioselective synthesis of 2-[18F]fluoro-L-tyrosine by catalytic phase-transfer alkylation J Labelled Cpd Radiopharm 44 2001 S857 S859
K. Wienhard, K. Herholz, and H.H. Coenen Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine [see comments] J Nucl Med 32 7 1991 1338 1346
W.A. Weber, H.J. Wester, and A.L. Grosu O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study Eur J Nucl Med 27 2000 542 549
A. Becherer, G. Karanikas, and M. Szabo Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine Eur J Nucl Med Mol Imaging 30 11 2003 1561 1567
B. Beuthien-Baumann, and J. Bredow 3-O-methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging Eur J Nucl Med Mol Imaging 30 7 2003 1004 1008
A.F. Shields PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls J Nucl Med 44 9 2003 1432 1434
T. Vander Borght, S. Pauwels, and L. Lambotte Brain tumor imaging with PET and 2-[carbon-11]thymidine J Nucl Med 35 6 1994 974 982
T. Ohtani, H. Kurihara, and S. Ishiuchi Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging Eur J Nucl Med 28 11 2001 1664 1670
T. Hara, T. Kondo, and N. Kosaka Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas J Neurosurg 99 3 2003 474 479
